Cargando…

Human Aquaporin 4 Gene Polymorphisms and Haplotypes Are Associated With Serum S100B Level and Negative Symptoms of Schizophrenia in a Southern Chinese Han Population

Background: Aquaporin 4 (AQP4) polymorphism may influence the required dosage of antipsychotic drugs. However, the roles of AQP4 polymorphisms in the blood—brain barrier (BBB) and different neuroprotective effects need further exploration. This study aims to investigate whether the gene polymorphism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yung-Fu, Sytwu, Huey-Kang, Lung, For-Wey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297372/ https://www.ncbi.nlm.nih.gov/pubmed/30618856 http://dx.doi.org/10.3389/fpsyt.2018.00657

Ejemplares similares

Polymorphisms in the Human Aquaporin 4 Gene Are Associated With Schizophrenia in the Southern Chinese Han Population: A Case–Control Study
por: Wu, Yung-Fu, et al.
Publicado: (2020)

Association between Interleukin-10 Gene Promoter Haplotype and Schizophrenia in a Han-Chinese Study
por: Peng, Hsin-Yi, et al.
Publicado: (2008)

Primary and Secondary Negative Symptoms in Schizophrenia
por: Mosolov, Sergey N., et al.
Publicado: (2022)

A Bioecosystem Theory of Negative Symptoms in Schizophrenia
por: Strauss, Gregory P.
Publicado: (2021)

Structure of Negative Symptoms in Schizophrenia: An Unresolved Issue
por: Russo, Manuela, et al.
Publicado: (2021)

Brain Structural Signatures of Negative Symptoms in Depression and Schizophrenia
por: Chuang, Jie-Yu, et al.
Publicado: (2014)

The Impact of Negative Symptoms and Neurocognition on Functioning in MDD and Schizophrenia
por: Quek, Yue Feng, et al.
Publicado: (2021)

Corrigendum: Structure of Negative Symptoms in Schizophrenia: An Unresolved Issue
por: Russo, Manuela, et al.
Publicado: (2022)

Synthetic Cannabinoids and Its Association With Persistent Negative Symptoms of Schizophrenia
por: Satodiya, Ritvij, et al.
Publicado: (2020)

Assessment and Treatment of Negative Symptoms in Schizophrenia—A Regional Perspective
por: Bitter, Istvan, et al.
Publicado: (2022)

Negative symptom dimensions and social functioning in Chinese patients with schizophrenia
por: Gao, Tianqi, et al.
Publicado: (2022)

Impact of negative symptoms on health-related quality of life in schizophrenia
por: Li, Yanhui, et al.
Publicado: (2023)

Autism Spectrum Disorder and Schizophrenia Are Better Differentiated by Positive Symptoms Than Negative Symptoms
por: Trevisan, Dominic A., et al.
Publicado: (2020)

Depressive Symptoms and PANSS Symptom Dimensions in Patients With Predominant Negative Symptom Schizophrenia: A Network Analysis
por: Demyttenaere, Koen, et al.
Publicado: (2022)

Optimal cutoff scores of the Chinese version of 15-item negative symptom assessment that indicate prominent negative symptoms of schizophrenia
por: Zhou, Qi, et al.
Publicado: (2023)

Solute Carrier Family 1 (SLC1A1) Contributes to Susceptibility and Psychopathology Symptoms of Schizophrenia in the Han Chinese Population
por: Li, Wenqiang, et al.
Publicado: (2020)

Magnetic Resonance Imaging in Studying Schizophrenia, Negative Symptoms, and the Glutamate System
por: Gruber, Oliver, et al.
Publicado: (2014)

Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptoms
por: Soontornniyomkij, Virawudh, et al.
Publicado: (2019)

Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits
por: Goldsmith, David R., et al.
Publicado: (2020)

Real-World Functioning in Patients With Schizophrenia: Beyond Negative and Cognitive Symptoms
por: García-Portilla, María Paz, et al.
Publicado: (2021)

Association Between Abundance of Haemophilus in the Gut Microbiota and Negative Symptoms of Schizophrenia
por: Zhu, Cuizhen, et al.
Publicado: (2021)

Use of Bupropion in the Management of Negative Symptom Schizophrenia: A Case Series
por: Perera, Pradilka, et al.
Publicado: (2022)

Positive Coping and Resilience as Mediators Between Negative Symptoms and Disability Among Patients With Schizophrenia
por: Chen, Haotian, et al.
Publicado: (2019)

The Cognitive Model of Negative Symptoms in Schizophrenia: A Hierarchical Component Model With PLS-SEM
por: Ebrahimi, Ali, et al.
Publicado: (2021)

Characteristics of Facial Muscle Activity Intensity in Patients With Schizophrenia and Its Relationship to Negative Symptoms
por: Du, Xia, et al.
Publicado: (2022)

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms
por: Vasiliu, Octavian
Publicado: (2021)

The efficacy of homestyle rehabilitation on negative symptoms in chronic schizophrenia: A randomized controlled trial
por: Chai, Jiabao, et al.
Publicado: (2023)

The mediating role of negative symptoms in “secondary factors” determining social functioning in chronic schizophrenia
por: Hu, Na, et al.
Publicado: (2023)

A Polymorphism in the BDNF Gene (rs11030101) is Associated With Negative Symptoms in Chinese Han Patients With Schizophrenia
por: Ping, Junjiao, et al.
Publicado: (2022)

Predicting Real-World Functioning in Schizophrenia: The Relative Contributions of Neurocognition, Functional Capacity, and Negative Symptoms
por: Yang, Zixu, et al.
Publicado: (2021)

Tracing Links Between Early Auditory Information Processing and Negative Symptoms in Schizophrenia: An ERP Study
por: Giordano, Giulia M., et al.
Publicado: (2021)

Association of DTNBP1 With Schizophrenia: Findings From Two Independent Samples of Han Chinese Population
por: Yang, Yongfeng, et al.
Publicado: (2020)

Sex Differences in the Association of HOMA-IR Index and BDNF in Han Chinese Patients With Chronic Schizophrenia
por: Yang, Yating, et al.
Publicado: (2021)

Impact of Positive Emotion Regulation Training on Negative Symptoms and Social Functioning in Schizophrenia: A Field Test
por: Favrod, Jérôme, et al.
Publicado: (2019)

Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia
por: Sehatpour, Pejman, et al.
Publicado: (2021)

Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia
por: Borovcanin, Milica M., et al.
Publicado: (2022)

The Relationship Between the Recognition of Basic Emotions and Negative Symptoms in Individuals With Schizophrenia Spectrum Disorders – An Exploratory Study
por: Zierhut, Marco, et al.
Publicado: (2022)

Validation of the French Clinical Assessment Interview for Negative Symptoms in a Sample of Stable French Individuals With Schizophrenia
por: Laraki, Yasmine, et al.
Publicado: (2022)

Association of Negative Symptoms of Schizophrenia Assessed by the BNSS and SNS Scales With Neuropsychological Performance: A Gender Effect
por: Wójciak, Paweł, et al.
Publicado: (2021)

Negative symptoms correlate with altered brain structural asymmetry in amygdala and superior temporal region in schizophrenia patients
por: Huang, Zetao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cl0v4c8am2cbrv5s6d7fid9eq0